[18]F-fluoroethyl-l-tyrosine positron emission tomography for radiotherapy target delineation: Results from a Radiation Oncology credentialing program

[18]F-fluoroethyl-l-tyrosine positron emission tomography for radiotherapy target delineation: Results from a Radiation Oncology credentialing program

Background and purpose: The [18]F-fluoroethyl-l-tyrosine (FET) PET in Glioblastoma (FIG) study is an Australian prospective, multi-centre trial evaluating FET PET for newly diagnosed glioblastoma management. The Radiation Oncology credentialing program aimed to assess the feasibility in Radiation On...

Full description

Bibliographic Details
Main Authors: Nathaniel Barry, Eng-Siew Koh, Martin A. Ebert, Alisha Moore, Roslyn J. Francis, Pejman Rowshanfarzad, Ghulam Mubashar Hassan, Sweet P. Ng, Michael Back, Benjamin Chua, Mark B. Pinkham, Andrew Pullar, Claire Phillips, Joseph Sia, Peter Gorayski, Hien Le, Suki Gill, Jeremy Croker, Nicholas Bucknell, Catherine Bettington, Farhan Syed, Kylie Jung, Joe Chang, Andrej Bece, Catherine Clark, Mori Wada, Olivia Cook, Angela Whitehead, Alana Rossi, Andrew Grose, Andrew M. Scott
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Physics and Imaging in Radiation Oncology
Subjects:
FET PET
Glioblastoma
Treatment planning
Credentialing
Clinical trials
Online Access:http://www.sciencedirect.com/science/article/pii/S2405631624000381

Internet

http://www.sciencedirect.com/science/article/pii/S2405631624000381

Similar Items